Literature DB >> 10940301

Tripartite regulation of Gln3p by TOR, Ure2p, and phosphatases.

P G Bertram1, J H Choi, J Carvalho, W Ai, C Zeng, T F Chan, X F Zheng.   

Abstract

Gln3p is a GATA-type transcription factor responsive to different nitrogen nutrients and starvation in yeast Saccharomyces cerevisiae. Recent evidence has linked TOR signaling to Gln3p. Rapamycin causes dephosphorylation and nuclear translocation of Gln3p, thereby activating nitrogen catabolite repressible-sensitive genes. However, a detailed mechanistic understanding of this process is lacking. In this study, we show that Tor1p physically interacts with Gln3p. An intact TOR kinase domain is essential for the phosphorylation of Gln3p, inhibition of Gln3p nuclear entry and repression of Gln3p-dependent transcription. In contrast, at least two distinct protein phosphatases, Pph3p and the Tap42p-dependent phosphatases, are involved in the activation of Gln3p. The yeast pro-prion protein Ure2p binds to both hyper- and hypo-phosphorylated Gln3p. In contrast to the free Gln3p, the Ure2p-bound Gln3p is signifcantly resistant to dephosphorylation. Taken together, these results reveal a tripartite regulatory mechanism by which the phosphorylation of Gln3p is regulated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940301     DOI: 10.1074/jbc.M004235200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  113 in total

1.  Genome-wide location and regulated recruitment of the RSC nucleosome-remodeling complex.

Authors:  Huck Hui Ng; François Robert; Richard A Young; Kevin Struhl
Journal:  Genes Dev       Date:  2002-04-01       Impact factor: 11.361

2.  Gln3p nuclear localization and interaction with Ure2p in Saccharomyces cerevisiae.

Authors:  A A Kulkarni; A T Abul-Hamd; R Rai; H El Berry; T G Cooper
Journal:  J Biol Chem       Date:  2001-06-14       Impact factor: 5.157

3.  Ammonia regulates VID30 expression and Vid30p function shifts nitrogen metabolism toward glutamate formation especially when Saccharomyces cerevisiae is grown in low concentrations of ammonia.

Authors:  G K van der Merwe; T G Cooper; H J van Vuuren
Journal:  J Biol Chem       Date:  2001-05-16       Impact factor: 5.157

4.  Chromatin-mediated regulation of nucleolar structure and RNA Pol I localization by TOR.

Authors:  Chi Kwan Tsang; Paula G Bertram; Wandong Ai; Ryan Drenan; X F Steven Zheng
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

Review 5.  Transmitting the signal of excess nitrogen in Saccharomyces cerevisiae from the Tor proteins to the GATA factors: connecting the dots.

Authors:  Terrance G Cooper
Journal:  FEMS Microbiol Rev       Date:  2002-08       Impact factor: 16.408

6.  Gln3 phosphorylation and intracellular localization in nutrient limitation and starvation differ from those generated by rapamycin inhibition of Tor1/2 in Saccharomyces cerevisiae.

Authors:  Kathleen H Cox; Ajit Kulkarni; Jennifer J Tate; Terrance G Cooper
Journal:  J Biol Chem       Date:  2003-12-16       Impact factor: 5.157

7.  Tor1/2 regulation of retrograde gene expression in Saccharomyces cerevisiae derives indirectly as a consequence of alterations in ammonia metabolism.

Authors:  Jennifer J Tate; Terrance G Cooper
Journal:  J Biol Chem       Date:  2003-07-07       Impact factor: 5.157

8.  Cytoplasmic compartmentation of Gln3 during nitrogen catabolite repression and the mechanism of its nuclear localization during carbon starvation in Saccharomyces cerevisiae.

Authors:  Kathleen H Cox; Jennifer J Tate; Terrance G Cooper
Journal:  J Biol Chem       Date:  2002-07-24       Impact factor: 5.157

9.  Constitutive and nitrogen catabolite repression-sensitive production of Gat1 isoforms.

Authors:  Rajendra Rai; Jennifer J Tate; Isabelle Georis; Evelyne Dubois; Terrance G Cooper
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

10.  The FKBP12-rapamycin-associated protein (FRAP) is a CLIP-170 kinase.

Authors:  Jae H Choi; Paula G Bertram; Ryan Drenan; John Carvalho; Heather H Zhou; X F Steven Zheng
Journal:  EMBO Rep       Date:  2002-09-13       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.